LONG-TERM RISK ASSESSMENT OF PROSTATE CANCER DIAGNOSIS IN MEN WITH INITIAL PSA-VALUES <1.0 NG/ML; RESULTS FROM THE SWISS ARM OF THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER (ERSPC)

被引：0

作者：

Seiler, Daniel

Randazzo, Marco

Isbarn, Hendrik

Chun, Felix

Ahyai, Sascha

Huber, Andreas

Grobholz, Rainer

Baumgartner, Martin

Recker, Franz

Kwiatkowski, Maciej

机构：

来源：

JOURNAL OF UROLOGY | 2012年 / 187卷 / 04期

关键词：

D O I：

10.1016/j.juro.2012.02.1089

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

988

引用

页码：E402 / E402

页数：1

共 50 条

[1] Prostate cancer risk assessment in men with an initial PSA below 3 ng/mL: results from the Goteborg randomized population-based prostate cancer screening trial
Franlund, Maria
Godtman, Rebecka Arnsrud
Carlsson, Sigrid, V
Lilja, Hans
Mansson, Marianne
Stranne, Johan
Hugosson, Jonas
SCANDINAVIAN JOURNAL OF UROLOGY, 2018, 52 (04) : 256 - 262
[2] Long-term prostate-specific antigen contamination in the Spanish arm of the European Randomized Study of Screening for Prostate Cancer (ERSPC)
Lujan, M.
Paez, A.
Angulo, J. C.
Granados, R.
Nevado, M.
Torres, G. M.
Berenguer, A.
ACTAS UROLOGICAS ESPANOLAS, 2016, 40 (03): : 164 - 172
[3] Association of Long-Term Dynamics in Circulating Testosterone with Serum PSA in Prostate Cancer-Free Men with Initial-PSA < 4 ng/mL
Wang, Kai
Chen, Xinguang
Cheng, Ting-Yuan David
Qiu, Peihua
Bird, Victoria Y.
Prosperi, Mattia
HORMONES & CANCER, 2019, 10 (4-6): : 168 - 176
[4] Final results of the initial and second prostate cancer screening round of the European randomized study of screening for prostate cancer (ERSPC, section Rotterdam)
Roobol, MJ
De Vries, SH
Schröder, FH
JOURNAL OF UROLOGY, 2004, 171 (04): : 165 - 165
[5] DISEASE-SPECIFIC SURVIVAL IN MEN WITH INTERVAL CANCERS COMPARED TO MEN WITH CANCERS IN THE CONTROL ARM: LONG-TERM RESULTS OF THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER (ERSPC)
Zhu, X.
Van Leeuwen, P. J.
Bul, M.
Bangma, C. H.
Schroder, F. H.
Roobol, M. J.
EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 35 - 35
[6] PROSTATE SPECIFIC ANTIGEN (PSA)-PYRAMID IN MEN WITH LOW RANGE PSA: PROSTATE CANCER INCIDENCE AND MORTALITY - A PLEA FOR RISK-BASED PROSTATE CANCER SCREENING STRATEGY IN THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER (ERSPC), AARAU
Randazzo, Marco
Seiler, Daniel
Beatrice, Josef
Baumgartner, Martin
Huber, Andreas
Grobholz, Rainer
Manka, Lukas
Ahyai, Sascha
Chun, Felix
Recker, Franz
Kwiatkowski, Maciej
JOURNAL OF UROLOGY, 2013, 189 (04): : E793 - E793
[7] Delays in cancer detection using 2 and 4 year screening intervals for prostate cancer screening in men with initial PSA < 2 ng/ml
Grubb, RL
Roehl, KA
Antenor, JAV
Catalona, WJ
JOURNAL OF UROLOGY, 2002, 167 (04): : 100 - 100
[8] DISEASE-SPECIFIC SURVIVAL IN MEN WITH INTERVAL CANCERS COMPARED TO MEN WITH CANCERS IN THE CONTROL ARM: LONG-TERM RESULTS OF THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER (ERSPC)-ROTTERDAM
Zhu, Xiaoye
van Leeuwen, Pim J.
Bul, Meelan
Bangma, Chris H.
Schroder, Fritz H.
Roobol, Monique J.
JOURNAL OF UROLOGY, 2011, 185 (04): : E813 - E813
[9] Digital rectal examination in prostate cancer screening at PSA level 3.0-3.9 ng/ml: long-term results from a randomized trial
Soronen, Veera
Talala, Kirsi
Raitanen, Jani
Taari, Kimmo
Tammela, Teuvo
Auvinen, Anssi
SCANDINAVIAN JOURNAL OF UROLOGY, 2021, 55 (05) : 348 - 353
[10] Serum testosterone:: A potentially adjunct screening test for the assessment of the risk of prostate cancer among men with modestly elevated PSA values (≥3.0 and <10.0 ng/ml)
Karamanolakis, Dimitrios
Lambou, Theocharis
Bogdanos, John
Milathianakis, Constantine
Sourla, Antigone
Lembessis, Peter
Halapas, Antonis
Pissimissis, Nicholas
Dessypris, Nick
Petridou, Eleni Th.
Koutsilieris, Michael
ANTICANCER RESEARCH, 2006, 26 (4B) : 3159 - 3166

← 1 2 3 4 5 →

LONG-TERM RISK ASSESSMENT OF PROSTATE CANCER DIAGNOSIS IN MEN WITH INITIAL PSA-VALUES &lt;1.0 NG/ML; RESULTS FROM THE SWISS ARM OF THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER (ERSPC)

LONG-TERM RISK ASSESSMENT OF PROSTATE CANCER DIAGNOSIS IN MEN WITH INITIAL PSA-VALUES <1.0 NG/ML; RESULTS FROM THE SWISS ARM OF THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER (ERSPC)